NeuroSense Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
NeuroSense Therapeutics Total Assets Growth & History (NRSN)
NeuroSense Therapeutics's total assets was $1.0M for fiscal 2025.
View full NeuroSense Therapeutics company overviewNeuroSense Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.0M | −$3.5M | −77.53% |
| 2024 | 2024-12-31 | $4.6M | $1.4M | +44.05% |
| 2023 | 2023-12-31 | $3.2M | −$4.5M | −58.81% |
| 2022 | 2022-12-31 | $7.7M | −$3.7M | −32.55% |
| 2021 | 2021-12-31 | $11.4M | $10.7M | +1367.39% |
| 2020 | 2020-12-31 | $779,000 | — | — |
NeuroSense Therapeutics quarterly total assets
Q4.20
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $1.0M | −$3.5M | −77.53% |
| Q2 2025 | 2025-06-30 | $1.7M | −$157,000 | −8.53% |
| Q4 2024 | 2024-12-31 | $4.6M | $1.4M | +44.05% |
| Q2 2024 | 2024-06-30 | $1.8M | −$6.0M | −76.60% |
| Q4 2023 | 2023-12-31 | $3.2M | −$4.5M | −58.81% |
| Q2 2023 | 2023-06-30 | $7.9M | −$3.6M | −31.30% |
| Q4 2022 | 2022-12-31 | $7.7M | −$3.7M | −32.55% |
| Q2 2022 | 2022-06-30 | $11.5M | — | — |
| Q4 2021 | 2021-12-31 | $11.4M | $10.7M | +1367.39% |
| Q4 2020 | 2020-12-31 | $779,000 | — | — |
NeuroSense Therapeutics total assets trends
Over the last five fiscal years, NeuroSense Therapeutics's total assets increased from $779,000 to $1.0M, a change of $249,000. The latest reported quarter, Q4 2025, shows $1.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NeuroSense Therapeutics source filings ↗